Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page
- Check7 days agoChange DetectedThe page's revision tag updates from v3.5.4 to v3.5.5, indicating a small history update. The change affects metadata only and does not modify the study information.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new internal version of the page rather than substantive content changes.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s footer/version identifier has been updated from `Revision: v3.5.2` to `Revision: v3.5.3`, reflecting a site software update rather than any change to the study record.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded 'Small cell lung carcinoma' to the Conditions list in the study details.SummaryDifference0.0%

- Check86 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. The study details content and eligibility information appear unchanged.SummaryDifference0.0%

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.